These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36930693)

  • 21. Effects of propofol on vasopressor use in patients with sepsis and severe sepsis: A pilot study.
    Marler J; Mohrien K; Kimmons LA; Vandigo JE; Oliphant CS; Boucher AN; Jones GM
    J Crit Care; 2016 Oct; 35():155-60. PubMed ID: 27481752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin.
    Rodriguez R; Cucci M; Kane S; Fernandez E; Benken S
    J Intensive Care Med; 2020 Apr; 35(4):327-337. PubMed ID: 30563433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Vasopressor Utilization Strategies and Outcomes in Critically Ill Patients With Severe Traumatic Brain Injury.
    Toro C; Ohnuma T; Komisarow J; Vavilala MS; Laskowitz DT; James ML; Mathew JP; Hernandez AF; Goldstein BA; Sampson JH; Krishnamoorthy V
    Anesth Analg; 2022 Dec; 135(6):1245-1252. PubMed ID: 35203085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients.
    Andrews L; Benken J; Benedetti E; Nishioka H; Pierce D; Dalton K; Han J; Shin B; Benken S
    Clin Transplant; 2022 Sep; 36(9):e14754. PubMed ID: 35771088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal VAsopressor TitraTION in patients 65 years and older (OVATION-65): protocol and statistical analysis plan for a randomised clinical trial.
    Masse MH; Battista MC; Wilcox ME; Pinto R; Marinoff N; D'Aragon F; St-Arnaud C; Mayette M; Leclair MA; Quiroz Martinez H; Grondin-Beaudoin B; Poulin Y; Carbonneau É; Seely AJE; Watpool I; Porteous R; Chassé M; Lebrasseur M; Lauzier F; Turgeon AF; Bellemare D; Mehta S; Charbonney E; Belley-Côté É; Botton É; Cohen D; Lamontagne F; Adhikari NKJ; ;
    BMJ Open; 2020 Nov; 10(11):e037947. PubMed ID: 33191251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3): protocol for a phase III, double-blind, randomised controlled trial.
    Chawla LS; Russell JA; Bagshaw SM; Shaw AD; Goldstein SL; Fink MP; Tidmarsh GF
    Crit Care Resusc; 2017 Mar; 19(1):43-49. PubMed ID: 28215131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early vs. Late Vassopressor therapy in the Management of Patients with Sepsis and Hypotension, A Multicenter Observational Study.
    Kusakabe A; Sweeny A; Keijzers G;
    Arch Med Res; 2021 Nov; 52(8):836-842. PubMed ID: 34275667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
    Wieruszewski PM; Wittwer ED; Kashani KB; Brown DR; Butler SO; Clark AM; Cooper CJ; Davison DL; Gajic O; Gunnerson KJ; Tendler R; Mara KC; Barreto EF
    Chest; 2021 Feb; 159(2):596-605. PubMed ID: 32882250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial.
    Santer P; Anstey MH; Patrocínio MD; Wibrow B; Teja B; Shay D; Shaefi S; Parsons CS; Houle TT; Eikermann M;
    Intensive Care Med; 2020 Oct; 46(10):1884-1893. PubMed ID: 32885276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II in septic shock.
    Jadhav AP; Sadaka FG
    Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between early vasopressor administration and in-hospital mortality in critically ill patients with acute pancreatitis: A cohort study from the MIMIC-IV database.
    Shi H; Sun SY; He YS; Peng Q
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(2):787-798. PubMed ID: 36734720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
    Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ
    Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial.
    Fraga CM; Tomasi CD; Damasio DC; Vuolo F; Ritter C; Dal-Pizzol F
    Crit Care; 2016 Oct; 20(1):331. PubMed ID: 27745551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Stratified outcomes of "Kidney Disease: Improving Global Outcomes" serum creatinine criteria in critical ill patients: a secondary analysis of a multicenter prospective study].
    Dong G; Qin J; An Y; Kang Y; Yu X; Zhao M; Ma X; Ai Y; Xu Y; Wang Y; Qian C; Wu D; Sun R; Li S; Hu Z; Cao X; Zhou F; Jiang L; Lin J; Chen E; Qin T; He Z; Zhou L; Du B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Mar; 32(3):313-318. PubMed ID: 32385995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower Versus Higher Exposure to Vasopressor Therapy in Vasodilatory Hypotension: A Systematic Review With Meta-Analysis.
    Richards-Belle A; Hylands M; Muttalib F; Taran S; Rochwerg B; Day A; Mouncey PR; Radermacher P; Couban R; Asfar P; Adhikari NKJ; Lamontagne F
    Crit Care Med; 2023 Feb; 51(2):254-266. PubMed ID: 36398968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of parameters associated with hypotension requiring vasopressor support after carotid angioplasty and stenting.
    Trocciola SM; Chaer RA; Lin SC; Ryer EJ; De Rubertis B; Morrissey NJ; McKinsey J; Kent KC; Faries PL
    J Vasc Surg; 2006 Apr; 43(4):714-20. PubMed ID: 16616226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Immediate-Release Nifedipine in Critically Ill Patients.
    Seto SL; Barra ME; Hamidi A; Sin JH; Devine LT
    J Pharm Pract; 2023 Jun; 36(3):614-619. PubMed ID: 35152786
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of Continuous Epinephrine Infusion on Survival in Critically Ill Patients: A Meta-Analysis of Randomized Trials.
    Belletti A; Nagy A; Sartorelli M; Mucchetti M; Putzu A; Sartini C; Morselli F; De Domenico P; Zangrillo A; Landoni G; Lembo R
    Crit Care Med; 2020 Mar; 48(3):398-405. PubMed ID: 31789701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults.
    Yunos NM; Bellomo R; Hegarty C; Story D; Ho L; Bailey M
    JAMA; 2012 Oct; 308(15):1566-72. PubMed ID: 23073953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.